Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Donna J. Affleck
[177Lu]-Dota0-Tyr3-Octreotate: A Potential Targeted Radiotherapeutic for the Treatment of Medulloblastoma
Current Radiopharmaceuticals
Nuclear Medicine
Radiology
Imaging
Pharmacology
Related publications
Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors With [177Lu-DOTA0,Tyr3]Octreotate
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Effects of Therapy With [177Lu-DOTA0,Tyr3]octreotate on Endocrine Function
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
P2.12-03 Phase I/Ii Trial of 177Lu-Dota0-Tyr3-Octreotate (Lutathera) and Nivolumab for Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Rapid Kit-Based 68Ga-Labelling and PET Imaging With THP-Tyr3-octreotate: A Preliminary Comparison With DOTA-Tyr3-octreotate
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
Potential Biomarkers for Radiation-Induced Renal Toxicity Following 177Lu-Octreotate Administration in Mice
PLoS ONE
Multidisciplinary
Nephrotoxicity After PRRT With 177Lu-Dota-Octreotate
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Utilization of Gold Containing Nanomaterials for Targeted Radiotherapeutic and Diagnostic Applications
Differences in Biodistribution Between99mTc-Depreotide,111In-Dtpa-Octreotide, And177Lu-Dota-Tyr3-Octreotate in a Small Cell Lung Cancer Animal Model
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
The Potential of Targeted Antiangiogenesis Therapies in the Treatment of Esophageal Cancer
Gastrointestinal Cancer: Targets and Therapy